Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia: A Cohort Study With Mediation Analysis

NCT07001865 is registered in ClinicalTrials.gov with Ningbo No. 1 Hospital as lead sponsor.

NCT NCT07001865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07001865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia: A Cohort Study With Mediation Analysis
Lead sponsor
Ningbo No. 1 Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 1, 2025
Completion date
December 31, 2025
Enrollment
17,040 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia, metabolic dysfunction-associated steatotic liver disease, metabolically healthy obesity